Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales expectations.
Read more...
Hence then, the article about zepbound sales keep soaring despite demand for weight loss drugs growing slower than expected was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected )
Also on site :
- X-Rite Pantone Demonstrates Advanced Color Management Solutions to Support Smart Manufacturing at MAX and American Coatings Show
- Five ways for motorists save on fuel and beat rising prices amid Iran War
- Stamus Networks introduit Suricata Language Server 2.0 avec des compétences d'agent d'intelligence artificielle et la prise en charge de l'intégration continue